Utama › Penyakit Hati Steatotik › California › Los Angeles
Kajian klinikal Penyakit Hati Steatotik di Los Angeles, CA
8 kajian untuk Penyakit Hati Steatotik sedang mencari peserta di lokasi dalam dan sekitar Los Angeles (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Mengambil pesertaFasa 3
- 89bio Clinical Study Site, Los Angeles
- 89bio Clinical Study Site, Los Angeles
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Mengambil pesertaFasa 2
- Keck Medical Center of USC, Los Angeles
- LAC + USC Medical Center, Los Angeles
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Mengambil pesertaFasa 3
- Los Angeles Institute for Metabolic Research, Los Angeles
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Mengambil pesertaFasa 3
- Akero Clinical Study Site, Los Angeles
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Mengambil pesertaFasa 3
- GSK Investigational Site, Los Angeles
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Mengambil pesertaFasa 2
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Mengambil pesertaFasa 3
- GSK Investigational Site, Los Angeles
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
- Velocity Clinical research, Los Angeles
Kajian Penyakit Hati Steatotik di bandar lain
- San Antonio, TX17 kajian
- New York City, NY16 kajian
- Miami, FL16 kajian
- San Diego, CA14 kajian
- Austin, TX13 kajian
- Houston, TX13 kajian
- Richmond, VA12 kajian
- Tucson, AZ10 kajian
- Chandler, AZ10 kajian
- Hialeah, FL9 kajian
- Dallas, TX9 kajian
- Orlando, FL9 kajian
Kajian lain di Los Angeles
- Kanser Paru-paru Bukan Sel Kecil87 kajian
- Kanser (semua jenis)74 kajian
- Kanser Payudara73 kajian
- Kanser Prostat61 kajian
- Kanser Kolorektal59 kajian
- Kanser Metastatik57 kajian
- Kanser Ovari50 kajian
- Kanser Paru-paru45 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher42 kajian
- Kanser Pankreas35 kajian
- Kanser Endometrium34 kajian
- Melanoma34 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.